Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03178344 · ClinicalTrials.gov registry record · NA
Effect of tACS Stimulation on Alpha Oscillations
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03178344 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 20 participants.
The verdict
NCT03178344, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Transcranial Alternating Current Stimulation (tACS) is one method that has been demonstrated to enhance alpha oscillations in healthy participants by applying weak electrical currents to the scalp to modulate rhythmic brain activity patterns. This study will involve tACS-induced frontal alpha oscillations, EEG recordings, and other physiological and biological measures.
Interventions
- DEVICE XCSITE100 Stimulator tACS
- DEVICE XCSITE100 Stimulator Sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2017-11-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03178344
The ClinicalTrials.gov registry entry for NCT03178344 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which XCSITE100 Stimulator tACS is the first listed.
NCT03178344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03178344 about?
NCT03178344 is a clinical study titled "Effect of tACS Stimulation on Alpha Oscillations". Transcranial Alternating Current Stimulation (tACS) is one method that has been demonstrated to enhance alpha oscillations in healthy participants by applying weak electrical currents to the scalp to modulate rhythmic brain activity patterns. This study will involve tACS-induced frontal alpha oscill...
What is the current status of trial NCT03178344?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-08-01. Estimated completion is 2017-11-04.
What interventions are being tested in trial NCT03178344?
The interventions under investigation include: XCSITE100 Stimulator tACS (DEVICE), XCSITE100 Stimulator Sham (DEVICE).
Who is sponsoring clinical trial NCT03178344?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.